These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 29342135)
1. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling. Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135 [TBL] [Abstract][Full Text] [Related]
2. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity. Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224 [TBL] [Abstract][Full Text] [Related]
3. The structural biology of the FGF19 subfamily. Beenken A; Mohammadi M Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159 [TBL] [Abstract][Full Text] [Related]
4. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions. Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552 [TBL] [Abstract][Full Text] [Related]
6. A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling. Shi SY; Lu YW; Richardson J; Min X; Weiszmann J; Richards WG; Wang Z; Zhang Z; Zhang J; Li Y Sci Rep; 2018 Jul; 8(1):11045. PubMed ID: 30038432 [TBL] [Abstract][Full Text] [Related]
7. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368 [TBL] [Abstract][Full Text] [Related]
8. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Itoh N Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630 [TBL] [Abstract][Full Text] [Related]
9. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling. Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288 [TBL] [Abstract][Full Text] [Related]
10. Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy. Itoh N; Ohta H; Konishi M Front Endocrinol (Lausanne); 2015; 6():154. PubMed ID: 26483756 [TBL] [Abstract][Full Text] [Related]
11. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340 [TBL] [Abstract][Full Text] [Related]
12. The FGF metabolic axis. Li X Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905 [TBL] [Abstract][Full Text] [Related]
13. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands. Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487 [TBL] [Abstract][Full Text] [Related]
14. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors. Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467 [TBL] [Abstract][Full Text] [Related]
15. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138 [TBL] [Abstract][Full Text] [Related]
16. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664 [TBL] [Abstract][Full Text] [Related]
17. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis? Ghanem M; Archer G; Crestani B; Mailleux AA Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for FGF hormone signalling. Chen L; Fu L; Sun J; Huang Z; Fang M; Zinkle A; Liu X; Lu J; Pan Z; Wang Y; Liang G; Li X; Chen G; Mohammadi M Nature; 2023 Jun; 618(7966):862-870. PubMed ID: 37286607 [TBL] [Abstract][Full Text] [Related]
19. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions. Kilkenny DM; Rocheleau JV Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737 [TBL] [Abstract][Full Text] [Related]
20. FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho. Suzuki Y; Kuzina E; An SJ; Tome F; Mohanty J; Li W; Lee S; Liu Y; Lax I; Schlessinger J Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31800-31807. PubMed ID: 33257569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]